# UPB (Upstream Bio, Inc.) - SEC EDGAR Financial Statements

> Upstream Bio, Inc. reported $2.87M in revenue and a net loss of $163.9M for the trailing twelve months ended September 30, 2026 (down 42.2% year over year), with a -6116.0% operating margin.

- Canonical: https://convexityos.com/fundamentals/UPB
- Markdown: https://convexityos.com/fundamentals/UPB.md
- SEC CIK: 0002022626
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:45 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002022626&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $2.87M | -42.2% YoY |
| Operating Income | TTM | -$175.5M | -6116.0% margin |
| Net Income | TTM | -$163.9M | -5712.3% net margin |
| Diluted EPS | TTM | -$2.99 | Split-adjusted |
| Free Cash Flow | TTM | -$133.4M | -4649.5% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $207.4M | Total debt: $789K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| **Revenue** | $2.85M | $2.37M | $2.38M |
| Research & Development | $136.8M | $62.97M | $31.80M |
| Total Operating Expenses | $163.2M | $80.13M | $42.49M |
| **Operating Income** | -$160.4M | -$77.76M | -$40.11M |
| **EBITDA** | -$160.2M | -$77.67M | -$40.05M |
| Interest Income | $16.93M | $12.12M | $4.17M |
| Income Tax Expense | $0 | $0 | $0 |
| **Net Income** | -$143.4M | -$62.81M | -$20.54M |
| Basic EPS | -$2.66 | -$5.58 | -$12.95 |
| **Diluted EPS** | -$2.66 | -$5.58 | -$12.95 |
| Basic Shares Outstanding | 53.9M | 13.7M | 3.0M |
| Diluted Shares Outstanding | 53.9M | 13.7M | 3.0M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $395K | $773K | $1.03M | $668K | $683K | $937K | $566K | $613K |
| Research & Development | $36.61M | $36.09M | $36.56M | $40.17M | $32.98M | $37.87M | $25.80M | $21.77M |
| Total Operating Expenses | $43.77M | $43.14M | $44.65M | $46.84M | $38.52M | $45.28M | $32.58M | $26.93M |
| **Operating Income** | -$43.38M | -$42.37M | -$43.62M | -$46.17M | -$37.83M | -$44.35M | -$32.01M | -$26.32M |
| **EBITDA** | -$43.33M | -$42.32M | -$43.57M | -$46.11M | -$37.79M | -$44.30M | -$31.97M | -$26.27M |
| Interest Income | $2.23M | $2.66M | $3.05M | $3.65M | $4.11M | $4.43M | $4.74M | $5.08M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$41.19M | -$39.70M | -$40.59M | -$42.46M | -$33.75M | -$39.97M | -$27.27M | -$21.24M |
| Basic EPS | -$0.75 | -$0.73 | -$0.75 | -- | -$0.63 | -$0.74 | -$0.51 | -- |
| **Diluted EPS** | -$0.75 | -$0.73 | -$0.75 | -- | -$0.63 | -$0.74 | -$0.51 | -- |
| Basic Shares Outstanding | 54.8M | 54.6M | 54.3M | -- | 53.9M | 53.8M | 53.6M | -- |
| Diluted Shares Outstanding | 54.8M | 54.6M | 54.3M | -- | 53.9M | 53.8M | 53.6M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | $101.6M | $325.9M | $25.83M |
| Short-Term Investments | $239.9M | $144.6M | $83.98M |
| **Cash & Short-Term Investments** | $341.5M | $470.5M | $109.8M |
| Accounts Receivable, Net | $668K | $613K | $98K |
| Other Current Assets | $727K | -- | -- |
| **Total Current Assets** | $351.8M | $479.2M | $117.0M |
| Property, Plant & Equipment, Net | $559K | $582K | $159K |
| Goodwill | -- | $0 | -- |
| **Total Non-Current Assets** | $1.98M | $2.56M | $202K |
| **Total Assets** | $353.8M | $481.7M | $117.2M |
| Accounts Payable | $2.73M | $4.04M | $1.99M |
| **Total Current Liabilities** | $13.45M | $10.74M | $6.51M |
| **Total Non-Current Liabilities** | $549K | $1.13M | $2.87M |
| **Total Liabilities** | $14.00M | $11.87M | $9.39M |
| **Total Debt (incl. Leases)** | $1.27M | $1.83M | $45K |
| Common Stock | $54K | $53K | $3.0K |
| Retained Earnings | -$334.2M | -$190.8M | -$128.0M |
| Accumulated Other Comp. Income | $530K | -$25K | $21K |
| **Total Stockholders' Equity** | $339.8M | $469.9M | -$123.1M |
| Total Equity | $339.8M | $469.9M | -$123.1M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $47.42M | $79.40M | $96.72M | $101.6M | $72.16M | $45.46M | $71.31M | $325.9M |
| Short-Term Investments | $159.9M | $181.9M | $197.9M | $239.9M | $300.3M | $348.1M | $360.1M | $144.6M |
| **Cash & Short-Term Investments** | $207.4M | $261.3M | $294.6M | $341.5M | $372.4M | $393.6M | $431.4M | $470.5M |
| Accounts Receivable, Net | $395K | $772K | $1.03M | $668K | $683K | $937K | $566K | $613K |
| Other Current Assets | $792K | $1.17M | -- | $727K | -- | -- | -- | -- |
| **Total Current Assets** | $244.6M | $279.6M | $316.3M | $351.8M | $389.0M | $418.3M | $453.8M | $479.2M |
| Property, Plant & Equipment, Net | $411K | $460K | $510K | $559K | $616K | $544K | $539K | $582K |
| Goodwill | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Non-Current Assets** | $1.36M | $1.57M | $1.77M | $1.98M | $2.18M | $2.25M | $2.38M | $2.56M |
| **Total Assets** | $246.0M | $281.2M | $318.1M | $353.8M | $391.2M | $420.5M | $456.2M | $481.7M |
| Accounts Payable | $2.38M | $2.31M | $1.71M | $2.73M | $3.95M | $2.55M | $4.72M | $4.04M |
| Other Current Liabilities | -- | -- | -- | -- | $55K | -- | -- | -- |
| **Total Current Liabilities** | $11.96M | $9.99M | $13.67M | $13.45M | $11.91M | $10.93M | $9.57M | $10.74M |
| **Total Non-Current Liabilities** | $57K | $226K | $390K | $549K | $703K | $849K | $992K | $1.13M |
| **Total Liabilities** | $12.02M | $10.21M | $14.06M | $14.00M | $12.61M | $11.78M | $10.56M | $11.87M |
| **Total Debt (incl. Leases)** | $789K | $954K | $1.11M | $1.27M | $1.42M | $1.56M | $1.70M | $1.83M |
| Common Stock | $54K | $54K | $54K | $54K | $56K | $54K | $53K | $53K |
| Retained Earnings | -$455.7M | -$414.5M | -$374.8M | -$334.2M | -$291.8M | -$258.0M | -$218.1M | -$190.8M |
| Accumulated Other Comp. Income | -$327K | -$123K | $100K | $530K | $493K | $258K | $368K | -$25K |
| **Total Stockholders' Equity** | $234.0M | $271.0M | $304.0M | $339.8M | $378.6M | $408.7M | $445.6M | $469.9M |
| Total Equity | $234.0M | $271.0M | $304.0M | $339.8M | $378.6M | $408.7M | $445.6M | $469.9M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Net Income | -$143.4M | -$62.81M | -$20.54M |
| Depreciation & Amortization | $188K | $89K | $60K |
| Stock-Based Compensation | $10.33M | $6.00M | $3.33M |
| Change in Payables | -$1.28M | $2.02M | $1.28M |
| **Operating Cash Flow** | -$133.3M | -$59.17M | -$37.93M |
| Capital Expenditure | -$165K | -$511K | -$144K |
| **Free Cash Flow** | -$133.4M | -$59.68M | -$38.07M |
| **Investing Cash Flow** | -$93.48M | -$59.48M | -$82.84M |
| **Financing Cash Flow** | $2.44M | $418.9M | $129.6M |
| **Net Change in Cash** | -$224.3M | $300.3M | $8.78M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$41.19M | -$39.70M | -$40.59M | -$42.46M | -$33.75M | -$39.97M | -$27.27M | -$21.24M |
| Depreciation & Amortization | $49K | $50K | $49K | $57K | $46K | $42K | $43K | $49K |
| Stock-Based Compensation | $4.34M | $4.35M | $4.65M | $2.51M | $2.59M | $2.60M | $2.63M | $2.09M |
| Change in Payables | $71K | $604K | -$1.02M | -$1.23M | $1.40M | -$2.17M | $711K | -$871K |
| **Operating Cash Flow** | -$54.23M | -$35.62M | -$47.85M | -$30.63M | -$22.24M | -$39.24M | -$41.16M | -$19.61M |
| **Investing Cash Flow** | $22.18M | $15.76M | $42.40M | $58.94M | $48.19M | $12.77M | -$213.4M | $41.91M |
| Common Stock Issued | $0 | $2.10M | $668.8M | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $69K | $2.53M | $598K | $1.10M | $760K | $612K | -$34K | $270.6M |
| **Net Change in Cash** | -$31.98M | -$17.33M | -$4.85M | $29.41M | $26.71M | -$25.85M | -$254.6M | $292.9M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| **Operating Margin** | -5618.8% | -3281.2% | -1685.5% |
| **Net Profit Margin** | -5026.0% | -2650.0% | -862.9% |
| Return on Equity (ROE) | -42.2% | -13.4% | -- |
| Return on Assets (ROA) | -40.5% | -13.0% | -17.5% |
| Current Ratio | 26.15x | 44.63x | 17.96x |
| Quick Ratio | 25.44x | 43.87x | 16.87x |
| Debt to Equity | 0.00x | 0.00x | -- |
| **Revenue Growth (YoY)** | +20.4% | -0.4% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -6116.0% | -5382.6% | -5176.5% | -5618.8% | -5020.1% | -4464.6% | -4127.4% | -3281.2% |
| **Net Profit Margin** | -5712.3% | -4955.7% | -4719.0% | -5026.0% | -4366.8% | -3836.6% | -3448.7% | -2650.0% |
| Return on Equity (ROE) | -70.1% | -57.8% | -51.6% | -42.2% | -32.3% | -25.6% | -17.8% | -13.4% |
| Return on Assets (ROA) | -66.6% | -55.7% | -49.3% | -40.5% | -31.2% | -24.8% | -17.4% | -13.0% |
| Current Ratio | 20.45x | 27.99x | 23.14x | 26.15x | 32.67x | 38.27x | 47.43x | 44.63x |
| Quick Ratio | 17.37x | 26.24x | 21.63x | 25.44x | 31.33x | 36.10x | 45.15x | 43.87x |
| Debt to Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| **Revenue Growth (YoY)** | -42.2% | -17.5% | +82.7% | +9.0% | +12.5% | +83.7% | -11.6% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
